ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 137 filers reported holding ARGENX SE in Q2 2019. The put-call ratio across all filers is 2.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $923,773 | +37.8% | 1,879 | +9.2% | 0.00% | +100.0% |
Q2 2023 | $670,336 | +72.2% | 1,720 | +64.6% | 0.00% | 0.0% |
Q1 2023 | $389,346 | -27.6% | 1,045 | -26.4% | 0.00% | 0.0% |
Q4 2022 | $537,939 | -3.4% | 1,420 | -10.0% | 0.00% | -33.3% |
Q3 2022 | $557,000 | -6.7% | 1,578 | +0.2% | 0.00% | 0.0% |
Q2 2022 | $597,000 | +20.1% | 1,575 | 0.0% | 0.00% | +50.0% |
Q1 2022 | $497,000 | -10.6% | 1,575 | -0.8% | 0.00% | 0.0% |
Q4 2021 | $556,000 | +16.8% | 1,587 | +0.8% | 0.00% | 0.0% |
Q3 2021 | $476,000 | +0.4% | 1,575 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $474,000 | +9.2% | 1,575 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $434,000 | -6.3% | 1,575 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $463,000 | +12.1% | 1,575 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $413,000 | +16.3% | 1,575 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $355,000 | +71.5% | 1,575 | 0.0% | 0.00% | +100.0% |
Q1 2020 | $207,000 | -18.2% | 1,575 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $253,000 | -18.6% | 1,575 | -28.4% | 0.00% | -50.0% |
Q2 2019 | $311,000 | +13.1% | 2,200 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $275,000 | – | 2,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |